BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Personalized medicine
,
Rosiglitazone
,
rs7903146
,
GATA1
,
glucose metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ketotifen
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Ketotifen is a microglial stabilizer by inhibiting secretory vesicle acidification.
Ex vivo analysis of ketotifen content in an antihistamine-eluting contact lens worn up to 5 hours.
Ketotifen is a Prodrug. Norketotifen is the active metabolite.
Comparison of Pregabalin and Ketotifen in treatment of uremic pruritus in hemodialysis patients.
Determining initial ocular comfort differences between 0.7% olopatadine and 0.035% ketotifen fumarat…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2
The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMI
Ketotifen in Non-Alcoholic Fatty Liver Disease Patients
Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19
Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ